€195.50
1.51%
Frankfurt, Sep 30, 12:52 pm CEST. Closed.
ISIN
DE0007474041
Symbol
PHH2

Paul Hartmann Stock price

€195.50
-4.50 2.25% 1M
-16.50 7.78% 6M
-34.50 15.00% YTD
-28.50 12.72% 1Y
+0.50 0.26% 3Y
-170.50 46.58% 5Y
-196.55 50.13% 10Y
+44.00 29.04% 20Y
Frankfurt, Closing price Wed, Sep 30 2026
-3.00 1.51%
ISIN
DE0007474041
Symbol
PHH2

Is Paul Hartmann a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
€709.1m
Enterprise Value
€1.0b
Net debt
€329.1m
Cash
-
Shares outstanding
3.6m
Valuation (TTM | estimate)
P/E
6.9
P/S
0.3 | -
EV/Sales
0.4 | -
EV/FCF
3.9
P/B
0.6
Dividends
DPS
€8.00
Yield 1Y | 5Y
4.0% | 3.1%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
46.4% | 43.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€2.5b | -
EBITDA
€279.2m
EBIT
€167.7m
Net Income
€99.9m
Free Cash Flow
€265.4m
Growth (TTM | estimate)
Revenue
2.5% | -
EBITDA
27.6%
EBIT
50.0%
Net Income
22.5%
Free Cash Flow
96.9%
Margin
Gross
61.2%
EBITDA
11.2%
EBIT
6.7%
Net
4.0%
Free Cash Flow
10.7%
Financial Health
Equity Ratio
54.4%
Return on Equity
5.2%
ROCE
10.3%
ROIC
-
Debt/Equity
0.3
More
EPS
€28.1
FCF per Share
€74.8
Short interest
-
Employees
10k
Rev per Employee
€240.0k

Financial data from Paul Hartmann

Jun '26
+/-
%
2,488 2,488
3% 3%
100%
- Direct Costs 965 965
2% 2%
39%
1,523 1,523
5% 5%
61%
- Selling and Administrative Expenses 695 695
2% 2%
28%
- Research and Development Expense - -
-
-
279 279
28% 28%
11%
- Depreciation and Amortization 111 111
4% 4%
4%
EBIT (Operating Income) EBIT 168 168
50% 50%
7%
Net Profit 100 100
23% 23%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about Paul Hartmann directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through the following business segments: Wound Management, Incontinence Management, Infection Management, and Other Group Activities. The Wound Management segment includes wound dressing and products for compression therapy and immobilization. The Incontinence Management segment provides incontinence hygiene, medical records, and products for patient and medical skin care. The Infection Management segment consists of surgery sets, surgical clothing, and surgical examination gloves. The Other Group Activities segment focuses on the areas of cotton wool products, feminine hygiene, baby hygiene, medical consumer goods, medicated and dietary supplements, body care and bath products, and commercial business. The company was founded in 1818 and is headquartered in Heidenheim, Germany.

Head office Germany
CEO Ms. Fuenfstueck
Employees 10,066
Founded 1818
Website www.hartmann.info

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today